Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBk. Cyprus Hldg Regulatory News (BOCH)

Share Price Information for Bk. Cyprus Hldg (BOCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 320.00
Bid: 321.00
Ask: 322.00
Change: -1.00 (-0.31%)
Spread: 1.00 (0.312%)
Open: 322.00
High: 322.00
Low: 320.00
Prev. Close: 321.00
BOCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Project Helix

19 Mar 2019 15:16

RNS Number : 3441T
Bank of Cyprus Holdings PLC
19 March 2019
 

Announcement

 

Update on Project Helix - Agreement for the sale of a portfolio of non-performing loans

 

 

Nicosia, 19 March 2019

 

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014

 

 

Further to the announcement of 28 August 20181 in relation to the agreement for the sale of a portfolio of non-performing loans, known as "Project Helix", or the "Transaction", Bank of Cyprus Holdings Public Limited Company ("BOCH" and, together with its subsidiaries, the "Group") announces that it has received approval from the ECB for the Significant Risk Transfer ("SRT") benefit from the Transaction.

This is an important step towards completion of the Transaction, which remains subject to various outstanding conditions precedent1. Completion is currently expected to occur in early 2Q2019.

As previously reported, the Transaction reduces the Group's non-performing exposures (NPEs) by €2.7 bn and improves the NPE ratio from 47% to 36%3. The NPE provisioning coverage ratio pro forma for the Transaction stands at 47%3.

On completion, the derecognition of the Helix portfolio is expected to have a positive impact on the capital ratios of 160 basis points2, resulting from the release of risk weighted assets.

As at 31 December 2018, as previously reported, the Group's phased-in CET1 ratio and Total capital ratio, pro forma for both DTC2 and Helix, stood at 15.4% and 18.3% respectively.

For further information, please contact Investor Relations at investors@bankofcyprus.com.

[1] Further to the announcement of 28 August 2018 and updates provided with the publication of the Group financial results for the nine months ended 30 September 2018 and the preliminary Group financial results for the year ended 31 December 2018

2 Refer to slide 36 of the presentation for the preliminary Group financial results for the year ended 31 December 2018 published on 4 March 2019

3 Based on the preliminary Group financial results for the year ended 31 December 2018

4 DTC refers to the amendments in the legislation adopted by the Cyprus Parliament on 1 March 2019 and was published on the Official Gazette of the Republic on 15 March 2019

 

 

Group Profile

 

The Bank of Cyprus Group is the leading banking and financial services group in Cyprus, providing a wide range of financial products and services which include retail and commercial banking, finance, factoring, investment banking, brokerage, fund management, private banking, life and general insurance. The Bank of Cyprus Group operates through a total of 112 branches in Cyprus. Bank of Cyprus also has representative offices in Russia, Ukraine and China. The Bank of Cyprus Group employs 4,146 staff worldwide. At 31 December 2018, the Group's Total Assets amounted to €22.1 bn and Total Equity was €2.4 bn. The Bank of Cyprus Group comprises Bank of Cyprus Holdings Public Limited Company, its subsidiary Bank of Cyprus Public Company Limited and its subsidiaries.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FURLLFLEVVIALIA
Date   Source Headline
1st Sep 20217:27 amRNSHalf-year Report -4
1st Sep 20217:20 amRNSHalf-year Report -3
1st Sep 20217:03 amRNSHalf-year Report -2
1st Sep 20217:02 amRNSDoc re. (1H2021 Investor Presentation)
1st Sep 20217:00 amRNS1H2021 Group Financial Results
1st Sep 20217:00 amRNSHalf-year Report -1
20th Aug 20218:53 amRNSDate of announcement of 1H2021 FR
23rd Jul 202110:55 amRNSRenewal of collective agreement
28th Jun 202111:24 amRNSCompletion of Project Helix 2 (Portfolios A and B)
23rd Jun 20219:38 amRNSDirector/PDMR Shareholding- Iordanou
16th Jun 20214:23 pmRNSIssue of Debt
16th Jun 20218:14 amRNSTR-1 Notification - Carval
9th Jun 202110:03 amRNSDirector/PDMR Shareholding
8th Jun 202110:14 amRNSDirector/PDMR Shareholding- Iordanou
4th Jun 202110:04 amRNSDirector/PDMR Shareholding- Iordanou
3rd Jun 20211:34 pmRNSDirector/PDMR Shareholding - Iordanou
2nd Jun 20218:35 amRNSDirector/PDMR Shareholding- Mr. Iordanou
2nd Jun 20218:32 amRNSDirector/PDMR Shareholding- Mr. Iordanou
2nd Jun 20218:31 amRNSDirector/PDMR Shareholding- Mr. Iordanou
1st Jun 20217:00 amRNSPDMR Notification of Transaction - Iordanou
28th May 20212:07 pmRNSAnnouncement
25th May 202112:34 pmRNSResult of AGM
25th May 20217:02 amRNSDoc re. (1Q2021 Investor Presentation)
25th May 20217:00 amRNS1Q2021 Group Financial Results
17th May 20214:40 pmRNSSecond Price Monitoring Extn
17th May 20214:35 pmRNSPrice Monitoring Extension
12th May 20217:09 amRNSDate of announcement of 1Q2021 FR
29th Apr 20214:40 pmRNSSecond Price Monitoring Extn
29th Apr 20214:35 pmRNSPrice Monitoring Extension
26th Apr 202110:17 amRNSNotice of AGM
21st Apr 202110:54 amRNSResults of Cash Tender Offer
20th Apr 20212:23 pmRNSIssue of Tier 2 Capital Notes - Replacement
16th Apr 20216:01 pmRNSIssue of Tier 2 Capital Notes
7th Apr 20211:18 pmRNSPillar 3 Disclosures 2020
7th Apr 202111:30 amRNSTR-1 Notification - Carval
30th Mar 20217:03 amRNSBOC Annual Financial Report 2020
30th Mar 20217:02 amRNSDoc re. (FY2020 Investor Presentation)
30th Mar 20217:02 amRNSBOCH Annual Financial Report 2020
30th Mar 20217:00 amRNSFY2020 Group Financial Results - Final
22nd Mar 20217:52 amRNSAnnouncement Date of Audited FY2020 FS
10th Mar 20212:19 pmRNSUpdate - Migration of BOCH shares to the Euroclear
1st Mar 202112:54 pmRNSAppointment of New Director
26th Feb 20214:40 pmRNSSecond Price Monitoring Extn
26th Feb 20214:35 pmRNSPrice Monitoring Extension
24th Feb 20217:04 amRNSDoc re. (Prelim FY2020 Investor Presentation)
24th Feb 20217:00 amRNSFY2020 Preliminary Group Financial Results
22nd Feb 20213:18 pmRNSDate of AGM
19th Feb 20214:41 pmRNSSecond Price Monitoring Extn
19th Feb 20214:36 pmRNSPrice Monitoring Extension
11th Feb 202112:01 pmRNSDate of Announcement of Preliminary FY2020 FR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.